المؤلفون: Hussein, Humaira

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, SGLT-2i, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), blood-glucose, Type 2 diabetes, thesis

الوصول الحر: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.890436Test

المؤلفون: Vanessa C. Brunetti, Audray St-Jean, Sophie Dell’Aniello, Anat Fisher, Oriana H. Y. Yu, Shawn C. Bugden, Jean-Marc Daigle, Nianping Hu, Silvia Alessi-Severini, Baiju R. Shah, Paul E. Ronksley, Lisa M. Lix, Pierre Ernst, Kristian B. Filion, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators

المصدر: BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-13 (2022)

مصطلحات موضوعية: Type 2 diabetes, sodium-glucose co-transporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, dipeptidyl peptidase 4 inhibitors, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1472-6823Test

الوصول الحر: https://doaj.org/article/4dd7ea64c43847aeb774db5960cf2f58Test

المؤلفون: Lin, J, Pearson, SA, Greenfield, JR, Park, KH, Havard, A, Brieger, D, Day, RO, Falster, MO, de Oliveira Costa, J

المصدر: urn:ISSN:0031-6970 ; urn:ISSN:1432-1041 ; European Journal of Clinical Pharmacology, 79, 9, 1239-1248

مصطلحات موضوعية: Cardiovascular, Diabetes, Metabolic and endocrine, 3 Good Health and Well Being, Humans, Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor, Australia, Hypoglycemic Agents, Cardiovascular Diseases, Symporters, Glucose, Sodium, Cardiovascular disease, Glucagon-like peptide-1 receptor agonists, Pharmacoepidemiology, Sodium-glucose co-transporter 2 inhibitors, Trends, Type 2 diabetes, anzsrc-for: 1115 Pharmacology and Pharmaceutical Sciences

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/1959.4/102334Test; https://unsworks.unsw.edu.au/bitstreams/3c4ce74b-2f85-4002-8e12-99a19a6e2148/downloadTest; https://doi.org/10.1007/s00228-023-03539-8Test

الإتاحة: https://doi.org/10.1007/s00228-023-03539-8Test
http://hdl.handle.net/1959.4/102334Test
https://unsworks.unsw.edu.au/bitstreams/3c4ce74b-2f85-4002-8e12-99a19a6e2148/downloadTest

المؤلفون: Louisa Sukkar, Tamara Young, Meg J. Jardine

المصدر: Kidney & Blood Pressure Research, Vol 45, Iss 6, Pp 823-836 (2020)

مصطلحات موضوعية: type 2 diabetes, cardiovascular disease, sodium-glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, Dermatology, RL1-803, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

العلاقة: https://www.karger.com/Article/FullText/511214Test; https://doaj.org/toc/1420-4096Test; https://doaj.org/toc/1423-0143Test

الوصول الحر: https://doaj.org/article/3668b3133c144a32af5b40863f841954Test

المؤلفون: Marcin Makuch, Marcelina Makuch, Ewa Krzewicka-Romaniuk, Grzegorz Dzida

المصدر: Journal of Education, Health and Sport, Vol 9, Iss 9, Pp 42-49 (2019)

مصطلحات موضوعية: sodium-glucose co-transporter 2 inhibitors, glucose, type 2 diabetes, cardiovascular effects, Education, Sports, GV557-1198.995, Medicine

وصف الملف: electronic resource

العلاقة: http://www.ojs.ukw.edu.pl/index.php/johs/article/view/7297Test; https://doaj.org/toc/2391-8306Test

الوصول الحر: https://doaj.org/article/bd36388d027947959e41163e36403d36Test

المؤلفون: Andrej Janez, Manfredi Rizzo, Djordje S. Popovic, Anca Pantea Stoian, Nikolaos Papanas, Ali A. Rizvi

المساهمون: Popovic D.S., Papanas N., Pantea Stoian A., Rizvi A.A., Janez A., Rizzo M.

المصدر: Diabetes Therapy

مصطلحات موضوعية: medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), 1 receptor agonists, Sodium-glucose co-transporter , Endocrinology, Diabetes and Metabolism, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19, Dipeptidyl peptidase , Review, Type 2 diabetes, Sodium-glucose co-transporter 2 inhibitors, Glucagon-like peptide 1 receptor agonists, Diabetes mellitus, Pandemic, Internal Medicine, medicine, 2 diabetes, Intensive care medicine, Antidiabetic agents, 4 inhibitors, Glucagon-like peptide , business.industry, COVID-19, medicine.disease, Systemic inflammatory response syndrome, Shock (circulatory), Dipeptidyl peptidase 4 inhibitors, medicine.symptom, business, 2 inhibitors, Type 

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5299514d22a08c56c16759e41199dfebTest
https://doi.org/10.1007/s13300-021-01170-3Test

المؤلفون: Makuch, Marcin, Makuch, Marcelina, Krzewicka-Romaniuk, Ewa, Dzida, Grzegorz

المصدر: Journal of Education, Health and Sport; Tom 9 Nr 9 (2019); 42-49 ; Journal of Education, Health and Sport; Vol. 9 No. 9 (2019); 42-49 ; 2391-8306

مصطلحات موضوعية: sodium-glucose co-transporter 2 inhibitors, glucose, type 2 diabetes, cardiovascular effects

وصف الملف: application/pdf

العلاقة: https://apcz.umk.pl/JEHS/article/view/7297/23029Test; https://apcz.umk.pl/JEHS/article/view/7297Test

الإتاحة: https://apcz.umk.pl/JEHS/article/view/7297Test

المؤلفون: Anastasios Tentolouris, Panayotis Vlachakis, Evangelia Tzeravini, Ioanna Eleftheriadou, Nikolaos Tentolouris

المصدر: International Journal of Environmental Research and Public Health; Volume 16; Issue 16; Pages: 2965

مصطلحات موضوعية: type 2 diabetes, sodium-glucose co-transporter 2 inhibitors, glycemic control, cardiovascular disease, cardioprotective mechanisms, adverse effects, empagliflozin, dapagliflozin, canagliflozin, ertugliflozin

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: https://dx.doi.org/10.3390/ijerph16162965Test

الإتاحة: https://doi.org/10.3390/ijerph16162965Test

المؤلفون: Adrian F. Hernandez, Silvio E. Inzucchi, John J.V. McMurray, F Martinez, Fredrik Öhrn, Rudolf A. de Boer, Scott D. Solomon, Mikhail Kosiborod, Ulrica Wilderäng, David L. DeMets, Anna Maria Langkilde, Brian Claggett, Daniel Lindholm, Sanjiv J. Shah, Carolyn S.P. Lam, Magnus Petersson

المساهمون: Cardiovascular Centre (CVC)

المصدر: European Journal of Heart Failure, 23(7), 1217-1225. Wiley
European Journal of Heart Failure

مصطلحات موضوعية: medicine.medical_specialty, Heart disease, Population, Trial Designs, Type 2 diabetes, 030204 cardiovascular system & hematology, Ventricular Function, Left, Sodium–glucose co‐transporter 2 inhibitors, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Internal medicine, medicine, Humans, Multicenter Studies as Topic, Dapagliflozin, Benzhydryl Compounds, education, Randomized Controlled Trials as Topic, Heart Failure, education.field_of_study, Ejection fraction, Study Design, business.industry, Stroke Volume, medicine.disease, Heart failure with preserved ejection fraction, chemistry, Diabetes Mellitus, Type 2, Heart failure, Cardiology, Mildly reduced ejection fraction, Sodium–glucose co-transporter 2 inhibitors, Cardiology and Cardiovascular Medicine, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c4bd18c86bd597f2d899c0e3878b71aTest
https://hdl.handle.net/11370/144be7a5-7a41-419f-a400-981535315061Test

المؤلفون: Lars Lund, Giuseppe M.C. Rosano, Yuksel Cavusoglu, Gerasimos Filippatos, Massimo F Piepoli, Frank Ruschitzka, Krishna Prasad, Brenda Moura, Mark C. Petrie, Tiny Jaarsma, Jelena Celutkiene, Marija Polovina, Tuvia Ben Gal, Christian Mueller, Petar M. Seferovic, Gabriele Fragasso, Mitja Lainscak, Stefan Heymans, Marco Metra, Wilfried Mullens, Andrew J.S. Coats, Ovidiu Chioncel, Giuseppe Dattilo, Giuseppe Ambrosio, Pardeep S. Jhund, Alexander R. Lyon, Robin Ray, Thomas Thum, Johann Bauersachs, Piotr Ponikowski, Loreena Hill, Stefan D. Anker, Jelena P. Seferovic, Ewa A. Jankowska, Francesco Cosentino, Rudolf A. de Boer, Roberto Ferrari, Yuri Lopatin

المساهمون: Cardiovascular Centre (CVC), RS: Carim - H02 Cardiomyopathy, MUMC+: MA Med Staf Spec Cardiologie (9), Cardiologie

المصدر: European Journal of Heart Failure, 22(9), 1495-1503. Wiley
European journal of heart failure, 22(9), 1495-1503. Wiley

مصطلحات موضوعية: MECHANISM, RATIONALE, Type 2 diabetes, 030204 cardiovascular system & hematology, Ventricular Function, Left, SGLT2 INHIBITORS, chemistry.chemical_compound, 0302 clinical medicine, SERUM URIC-ACID, Medicine, Dapagliflozin, Canagliflozin, Heart failure, Sodium–glucose co-transporter 2 inhibitors, Type 2 diabetes mellitus, Cardiovascular outcomes, Quality of life, Ejection fraction, SGLT2 inhibitors, cardiovascular outcomes, heart failure, quality of life, type 2 diabetes, Symporters, EMPAGLIFLOZIN, 3. Good health, Cardiology, Cardiology and Cardiovascular Medicine, medicine.drug, Sodium-glucose co-transporter 2 inhibitors, medicine.medical_specialty, DAPAGLIFLOZIN, Glycemic Control, 03 medical and health sciences, Diabetes mellitus, Internal medicine, Empagliflozin, Humans, Sodium-Glucose Transporter 2 Inhibitors, business.industry, MORTALITY, Sodium, Type 2 Diabetes Mellitus, Stroke Volume, DIABETES-MELLITUS, KIDNEY-DISEASE, medicine.disease, Glucose, chemistry, Diabetes Mellitus, Type 2, business, RESISTANCE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5619d762d08f955c6017343e71b8ad7Test
https://doi.org/10.1002/ejhf.1954Test